This Bull Market Indicator called NVDA at $116

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

Craig E. Hunsaker net worth and biography

Craig Hunsaker Biography and Net Worth

EVP of Alphatec

Craig Hunsaker has served as Executive Vice President, People & Culture since September 2016, and as General Counsel since March 2017. In these roles, he is responsible for all aspects of employee recruitment, development, engagement and corporate culture, and is the Company’s chief legal officer and Corporate Secretary. Craig's professional career includes 16 years practicing law at some of the world's largest technology focused law firms, advising and defending companies and management with respect to their people and trade secrets decisions, while holding various leadership positions. Craig left full-time legal practice in 2009, when he joined NuVasive, Inc., a publicly traded spinal implant company, first to serve as Vice President, Legal Affairs, then as Senior Vice President, Global Human Resources until March 2014. From April 2014 until he joined Alphatec Spine, Craig owned a consulting business, assisting employers in the areas of Employment Law and Human Resources, including as Senior Advisor, Human Resources at General Atomics, a San Diego-based defense contractor. Craig received his J.D. from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar, and his B.S. in International Business & Finance from Brigham Young University.

What is Craig E. Hunsaker's net worth?: The estimated net worth of Craig E. Hunsaker is at least $11.80 million as of February 26th, 2024. Mr. Hunsaker owns 1,188,444 shares of Alphatec stock worth more than $11,801,249 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Hunsaker may own. Additionally, Mr. Hunsaker receives a salary of $909,330.00 as EVP at Alphatec. Learn More about Craig E. Hunsaker's net worth.
How old is Craig E. Hunsaker?: Mr. Hunsaker is currently 60 years old. There are 6 older executives and no younger executives at Alphatec. The oldest executive at Alphatec is Mr. Jonathan Allen, Executive Vice President of Commercial Operations, who is 64 years old. Learn More on Craig E. Hunsaker's age.
What is Craig E. Hunsaker's salary?: As the EVP of Alphatec Holdings, Inc., Mr. Hunsaker earns $909,330.00 per year. The highest earning executive at Alphatec is Mr. Patrick S. Miles, Executive Chairman, CEO & President, who commands a salary of $1,590,000.00 per year. Learn More on Craig E. Hunsaker's salary.
How do I contact Craig E. Hunsaker?: The corporate mailing address for Mr. Hunsaker and other Alphatec executives is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. Alphatec can also be reached via phone at (760) 431-9286 and via email at [email protected]. Learn More on Craig E. Hunsaker's contact information.
Has Craig E. Hunsaker been buying or selling shares of Alphatec?: Craig E. Hunsaker has not been actively trading shares of Alphatec during the last quarter. Most recently, Craig E. Hunsaker sold 41,560 shares of the business's stock in a transaction on Monday, February 26th. The shares were sold at an average price of $15.05, for a transaction totalling $625,478.00. Following the completion of the sale, the executive vice president now directly owns 1,188,444 shares of the company's stock, valued at $17,886,082.20. Learn More on Craig E. Hunsaker's trading history.
Who are Alphatec's active insiders?: Alphatec's insider roster includes Evan Bakst (Director), Jeffrey Black (CFO), Jason Hochberg (Director), Craig Hunsaker (EVP), Scott Lish (SVP), Patrick Miles (CEO), David Mowry (Director), David Pelizzon (Director), Jennifer Pritzker (Major Shareholder), Paul Segal (Major Shareholder), David Sponsel (EVP), and James Tullis (Director). Learn More on Alphatec's active insiders.
Are insiders buying or selling shares of Alphatec?: In the last twelve months, Alphatec insiders bought shares 3 times. They purchased a total of 85,000 shares worth more than $743,050.00. In the last twelve months, insiders at the medical technology company sold shares 12 times. They sold a total of 340,301 shares worth more than $4,593,019.43. The most recent insider tranaction occured on August, 21st when Director David M Demski bought 50,000 shares worth more than $283,500.00. Insiders at Alphatec own 22.8% of the company. Learn More about insider trades at Alphatec.
Information on this page was last updated on 8/21/2024.

Craig E. Hunsaker Insider Trading History at Alphatec

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/26/2024	Sell	41,560	$15.05	$625,478.00	1,188,444
6/27/2023	Sell	6,542	$18.00	$117,756.00	1,220,914
5/15/2023	Sell	58,238	$15.29	$890,459.02	1,227,456
4/24/2023	Sell	28,311	$15.85	$448,729.35	1,285,694
3/1/2023	Sell	80,023	$16.00	$1,280,368.00	1,346,828
2/27/2023	Sell	36,072	$14.74	$531,701.28	1,436,789
2/21/2023	Sell	65,716	$14.04	$922,652.64	1,472,861
2/9/2023	Sell	60,000	$14.00	$840,000.00	1,435,995
8/17/2022	Sell	9,895	$9.07	$89,747.65	1,251,174
8/15/2022	Sell	30,000	$9.70	$291,000.00	1,261,969
6/13/2022	Sell	30,000	$7.31	$219,300.00	1,331,729
6/1/2022	Sell	70,000	$7.16	$501,200.00	1,362,229
11/12/2021	Buy	15,000	$11.66	$174,900.00
4/8/2021	Sell	25,000	$16.23	$405,750.00	1,008,361
10/8/2020	Sell	62,731	$8.62	$540,741.22	1,016,092
1/15/2020	Sell	32,000	$7.75	$248,000.00	794,948
11/18/2019	Sell	32,000	$7.25	$232,000.00	797,448
11/4/2019	Sell	12,000	$7.00	$84,000.00	844,768
10/31/2019	Sell	32,000	$6.75	$216,000.00	844,768
8/12/2019	Sell	100,000	$5.88	$588,000.00	811,112
8/8/2019	Sell	50,000	$5.75	$287,500.00	811,112
7/25/2019	Sell	50,000	$5.00	$250,000.00	811,112
5/15/2019	Sell	50,000	$4.50	$225,000.00
4/30/2019	Sell	50,000	$4.00	$200,000.00	626,014

Craig E. Hunsaker Buying and Selling Activity at Alphatec

Alphatec Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Today's Range

Now: $9.93

$9.54

$10.12

50 Day Range

MA: $6.52

$4.98

$9.93

2 Week Range

Now: $9.93

$4.88

$17.34

Volume

2,331,810 shs

Average Volume

1,965,051 shs

Market Capitalization

$1.41 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

This Bull Market Indicator called NVDA at $116

From WealthPress | Ad

All you have to do is follow this link here

Craig Hunsaker Biography and Net Worth

What is Craig E. Hunsaker's net worth?

How old is Craig E. Hunsaker?

What is Craig E. Hunsaker's salary?

How do I contact Craig E. Hunsaker?

Has Craig E. Hunsaker been buying or selling shares of Alphatec?

Who are Alphatec's active insiders?

Are insiders buying or selling shares of Alphatec?